Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_3
1
20%
Ph phase_2
2
40%
Ph not_applicable
2
40%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)

Detailed Status

Completed3
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (40.0%)
Phase 31 (20.0%)
N/A2 (40.0%)

Trials by Status

recruiting120%
completed360%
withdrawn120%

Recent Activity

1 active trials
Showing 5 of 5
recruitingnot_applicable

GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study

NCT05216042
completedphase_2

Race, Natriuretic Peptides and Physiological Perturbations

NCT03070184
withdrawnphase_2

Mechanistic Insights to Weight Loss Maintenance Through SGLT2 Inhibitors

NCT05885074
completednot_applicable

Exercise and Cognition Trials

NCT02958735
completedphase_3

Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected Asthmatics

NCT00252291

Clinical Trials (5)

Showing 5 of 5 trials
NCT05216042Not Applicable

GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study

Recruiting
NCT03070184Phase 2

Race, Natriuretic Peptides and Physiological Perturbations

Completed
NCT05885074Phase 2

Mechanistic Insights to Weight Loss Maintenance Through SGLT2 Inhibitors

Withdrawn
NCT02958735Not Applicable

Exercise and Cognition Trials

Completed
NCT00252291Phase 3

Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected Asthmatics

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5